Yeah. It’s going to get worse. The company has not ever been this quiet nor has it released any type of PR, sponsored, promo or anything else. No response after saying they were being #transparent 3-4 mos ago except a power point presentation to attract more investors and money. Cmon!!!!
It’s going to be really interesting to see their end of month quarterly for August and September, I think that’s when s hit the fan after people got fed up with 90-99% losses year after year after year.
If they stay on this path and more institutional and retail investors leave, it’s not recoverable imo.
Even if they tried, they could perhaps stave it off, but it looks like they are not even trying. #NoHope
A share buy back would deplete part of whatever is left of their millions in the bank which is most likely allocated to other things, such as their $8M IPO offering. Do they have to pay that back if they get booted from nasdaq? I don’t know the answer to that.
A reverse split to stay uplisted is just another red flag to all investors. We all know what that means.
I’d be concerned about if they have anymore convertible debt or other convertible debt by hard money loan sharks. That will likely either result in more shareholder dilution or hard cash, which they have apparently never used to improve shareholder communications or increase share price.
It’s seem their motto is just to enrich themselves and screw investors because every thing they’ve put out has a disclaimer saying it’s all subject to change and dependent on these bogus filings that they *ALWAYS* anticipate being approved.
Pretty much the only thing that was approved was adva-27a, which has been bouncing from corp to corp to corp because it’s not safe on humans. You have to get approval and go to stage 1, 2, and then 3, which takes 10-15 years for Big Pharma, not 3 people who work out of a fake virtual office for $300 a month with a business line that forwards to Camille’s expensed cell phone that investors pay for.
